Streetbeat News

Stock Prices

TSLA

CalPERS has announced its decision to vote against Elon Musk's multibillion-dollar pay package. This move could influence other shareholders and impact Tesla's stock price.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 9:03 pm

LLY

Analysts' ratings for Eli Lilly and Co (NYSE:LLY) show a mix of bullish and somewhat bullish sentiments, with recent price targets indicating an upward trend. The average 12-month price target is $865.18, reflecting a 5.99% increase from the previous average. Key financial metrics such as revenue growth, net margin, ROE, and ROA are strong, but the company faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

June 12, 2024 | 9:00 pm

XRAY

Dentsply Sirona has canceled its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:56 pm

SPCE

Virgin Galactic Holdings, Inc. (NYSE:SPCE) announced a 1-for-20 reverse stock split to meet NYSE listing requirements. The stock will trade on a split-adjusted basis starting June 17. Shares fell 20.17% after-hours following the announcement.

Portfolio Pulse from Erica Kollmann

June 12, 2024 | 8:50 pm

AVGO

Broadcom Inc (NASDAQ:AVGO) reported strong Q2 earnings, beating revenue and EPS estimates driven by AI demand. The company announced a 10-for-1 stock split and raised its fiscal-year 2024 revenue guidance. Shares rose 10.53% in after-hours trading.

Portfolio Pulse from Adam Eckert

June 12, 2024 | 8:44 pm

CLLS

Cellectis has published a scientific article in Nature Communications, revealing a non-viral gene therapy approach for treating Sickle Cell Disease.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:38 pm

JILL

J.Jill shares are trading lower following the company's announcement of a proposed public offering of common stock.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:35 pm

SPCE

Virgin Galactic shares are trading lower after the company announced it will effect a reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:34 pm

PFE

Pfizer announced that key secondary endpoints in a Phase 3 study of its investigational gene therapy, Fordadistrogene Movaparvovec, did not show a significant difference between participants treated with the therapy and those given a placebo.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:33 pm

SPCE

Virgin Galactic's board has approved a 1-for-20 reverse stock split, effective June 14, 2024, after market close. Split-adjusted trading will begin on June 17, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 8:32 pm